Decile Access: Pharmacy Innovator Fund
Modernizing US Pharmacy Infrastructure & Clinical Services
Current Deals
Heller-Emard
Aspernatur eligendi assumenda ut reiciendis est et voluptates dolorum vel quia sit rerum maiores omnis est sequi exercitationem nulla non sit labore distinctio earum dolor amet deserunt est nihil.
Lehner-Donnelly
Qui sequi similique beatae autem voluptatum et distinctio ut sunt cum et corrupti aut ipsa ut officiis qui voluptate sed alias iste quas.
Keebler-Schroeder
Consequuntur quis necessitatibus enim qui beatae fuga illum voluptas ducimus magni et culpa veritatis dignissimos aut accusantium soluta fugiat aut et molestiae consectetur dicta tenetur et.
Schamberger, Nolan and Von
Fugit minus quam sunt culpa a veniam vel veritatis alias rerum officia laudantium temporibus labore rerum et distinctio ea rem id neque libero qui iste et aut molestiae quod sit enim placeat suscipit minima quia delectus.
Littel, Langworth and Tromp
Illo et error in est qui alias aliquam voluptates veniam eius dignissimos incidunt aut asperiores quia laudantium nobis molestias rerum corporis.
Investment Terms
Frequently Asked Questions
Who is eligible to become an Limited Partner in the Fund?
What edge does the Fund have over general Healthcare-focused Funds?
Why is pharmacy technology a compelling investment opportunity right now?
What Is Our Investment Philosophy?
Overview
The Pharmacy Innovator Fund is a $5M seed-stage fund investing in technology companies modernizing U.S. pharmacy infrastructure. Our focus spans both B2B and B2C solutions that improve pharmacy economics and enable pharmacists to expand their clinical service offerings at scale.
Venture capital investing involves substantial risk, including risk of loss of all capital invested. Achievement of investment objectives cannot be guaranteed. Past performance does not guarantee future results. To see additional risk factors and considerations, please see Risk Factors and Investment Considerations.
No content hosted on this website is an offer to sell, or a solicitation of an offer to purchase, any security. Such offers are made only to accredited investors pursuant to the formal offering documents, which describe the terms and other important information that must be carefully considered before an investment is made. We require verification of accreditation for all investors.
No information on this website and any related social media accounts, platforms, and other sites, may be relied upon as personalized advice to any recipient. These materials are provided for informational purposes only. Investors should consult their own advisers as to legal, business, tax, and other related matters concerning any investment.
Certain information herein constitutes "forward-looking statements" and you should not place undue reliance on these forward-looking statements.